However, downregulation of XPC resulted in an increased phosphorylation of ERK1/2 in both A549 and H460 cell lines (Figures 5A-C), indicating that XPC is able to inhibit the ERK pathway in NSCLC cells. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.